Eisai
is a Japan-based pharmaceutical company that develops and commercializes prescription medicines and OTC drugs for the healthcare sector... Read moreEisai
is a Japan-based pharmaceutical company that develops and commercializes prescription medicines and OTC drugs for the healthcare sector... Read more
News
Apr 04, 2025
Northernindiaherald
Eisai: Lennox-Gastaut syndrome Market to Expand Significantly by 2034, States DelveInsight Report | Takeda, Ovid, SK Life Science, Epygenix, CuroNZ Ltd, Eisai
Apr 03, 2025
Marketscreener
Eisai: Citius Oncology, Inc. and Eisai Co., Ltd. Enter into Letter Agreement that Amends License Agreement to Provide for Payment Schedule to Eisai
Mar 28, 2025
Endpoints News
Eisai: DBV's financing for peanut allergy patch; Eisai divests proton pump inhibitor in China
Mar 26, 2025
BioSpace
Eisai: Eisai Lowers Sales Expectations for Leqembi Again, Citing Slow US Uptake
Mar 26, 2025
Voasg
Eisai: Eisai Selected as a Nadeshiko Brand 2025 as a Listed Company Excelling in Promotion of Women in the Workplace
Mar 25, 2025
Endpoints News
Eisai: Eisai cuts Leqembi 2027 sales projections by half
Mar 25, 2025
FinanzNachrichten
Eisai: BioArctic's partner Eisai presents sales simulation for Leqembi at its annual press conference
Mar 25, 2025
Pharmabiz
Eisai: Angle updates on AstraZeneca development work and Eisai's phase 2 pilot study
Mar 21, 2025
Advfn
Eisai: Angle hails successful completion of Eisai contract; approval by Astra
Mar 19, 2025
Gujaratmagazine
Eisai: Tonic clonic Seizure Market Growth to Accelerate in Forecast Period (2023-2032), DelveInsight Analyzes | Pfizer, GlaxoSmithKline, Eisai Inc., Xenon Pharma, UCB Pharma, Johnson & Johnson, Ono Pharma
Eisai Competitors
1
2
3
4
5
6
7
8
9
10